Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
1998-1-8
pubmed:abstractText
C-Myb is a sequence-specific DNA binding protein that regulates the expression of genes involved in cell proliferation and differentiation. The present study was designed to elucidate the role of c-Myb in the pathogenesis of chronic liver disease by an immunohistochemical approach. In normal (control) livers, few or no hepatic cells were positive for c-Myb. In livers from patients with chronic viral hepatitis, positive staining for c-Myb was found not only in spindle-shaped mesenchymal cells in expanded portal areas, but also in perisinusoidal cells (PSCs) within liver lobules. In cirrhotic livers, a few PSCs within lobules were positive for c-Myb, while no staining was seen in fibrous septa. Immunoelectron microscopy revealed that c-Myb-positive PSCs displayed morphological features of hepatic stellate cells. Other sinusoidal lining cells including Kupffer cells and sinusoidal endothelial cells, as well as hepatocytes, were all negative for c-Myb. Dual c-Myb/alpha-smooth muscle actin (alphaSMA) staining revealed that more than 97% of c-Myb-positive cells were alphaSMA-positive. Moreover, dual c-Myb/proliferating cell nuclear antigen (PCNA) staining showed that approximately 70% of c-Myb-positive cells also expressed PCNA. The labeling index (LI) (number of c-Myb-positive cells/0.1 mm2) significantly correlated with serum transaminase concentrations and increased in parallel with the disease activity. However, the LI showed no correlation with the degree of fibrosis. These results suggest that c-Myb may be involved in stellate cell activation and proliferation in chronically diseased human livers, and that the level of c-Myb expression is associated with the activity of chronic hepatitis.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0270-9139
pubmed:author
pubmed:issnType
Print
pubmed:volume
26
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1506-12
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:9397991-Actins, pubmed-meshheading:9397991-Adult, pubmed-meshheading:9397991-Antibodies, Monoclonal, pubmed-meshheading:9397991-Antibody Specificity, pubmed-meshheading:9397991-Biopsy, pubmed-meshheading:9397991-Blotting, Western, pubmed-meshheading:9397991-Chronic Disease, pubmed-meshheading:9397991-Female, pubmed-meshheading:9397991-Hepatitis, Viral, Human, pubmed-meshheading:9397991-Humans, pubmed-meshheading:9397991-Immunohistochemistry, pubmed-meshheading:9397991-Liver, pubmed-meshheading:9397991-Liver Cirrhosis, pubmed-meshheading:9397991-Liver Diseases, pubmed-meshheading:9397991-Liver Function Tests, pubmed-meshheading:9397991-Male, pubmed-meshheading:9397991-Microscopy, Immunoelectron, pubmed-meshheading:9397991-Middle Aged, pubmed-meshheading:9397991-Proto-Oncogene Proteins, pubmed-meshheading:9397991-Proto-Oncogene Proteins c-myb, pubmed-meshheading:9397991-Trans-Activators
pubmed:year
1997
pubmed:articleTitle
Hepatic expression of c-Myb in chronic human liver disease.
pubmed:affiliation
Department of Public Health, Osaka City University Medical School, Osaka, Japan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't